1.Goulart MO, Zani CL, Tonholo J, Freitas LR, de Abreu FC, Oliveira AB, Raslan DS, Starling S, Chiari E. (1997) Trypanocidal activity and redox potential of heterocyclic- and 2-hydroxy-naphthoquinones, 7 (15):[10.1016/S0960-894X(97)00354-5]
2.Wu C, Johnson RK, Mattern MR, Wong JC, Kingston DG.. (1999) Synthesis of furanonaphthoquinones with hydroxyamino side chains., 62 (7):[PMID:10425117][10.1021/np9900019]
3.Konoshima T, Kozuka M, Koyama J, Okatani T, Tagahara K, Tokuda H.. (1989) Studies on inhibitors of skin tumor promotion, VI. Inhibitory effects of quinones on Epstein-Barr virus activation., 52 (5):[PMID:2558164][10.1021/np50065a012]
4.Tseng CH, Chen YL, Yang SH, Peng SI, Cheng CM, Han CH, Lin SR, Tzeng CC.. (2010) Synthesis and antiproliferative evaluation of certain iminonaphtho[2,3-b]furan derivatives., 18 (14):[PMID:20591678][10.1016/j.bmc.2010.05.062]
5.Reichstein A, Vortherms S, Bannwitz S, Tentrop J, Prinz H, Müller K.. (2012) Synthesis and structure-activity relationships of lapacho analogues. 1. Suppression of human keratinocyte hyperproliferation by 2-substituted naphtho[2,3-b]furan-4,9-diones, activation by enzymatic one- and two-electron reduction, and intracellular generation of superoxide., 55 (16):[PMID:22845014][10.1021/jm3009597]
6.Löcken H, Clamor C, Müller K.. (2018) Napabucasin and Related Heterocycle-Fused Naphthoquinones as STAT3 Inhibitors with Antiproliferative Activity against Cancer Cells., 81 (7):[PMID:30003778][10.1021/acs.jnatprod.8b00247]
